Promis Neurosciences Inc (PMN.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 2 | 2 | 3 | 3 | 3 |
| Accounts receivable | N/A | N/A | N/A | N/A | -51 |
| Accounts payable and accrued liabilities | 4,002 | 1,157 | 1,027 | 261 | 230 |
| Other Working Capital | 2,227 | 3,782 | 1,155 | -107 | 573 |
| Other Operating Activity | -8,793 | -9,495 | -6,820 | -4,586 | -4,171 |
| Operating Cash Flow | $-2,562 | $-4,554 | $-4,636 | $-4,429 | $-3,416 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 0 | 0 | 0 | 0 | -2 |
| Investing Cash Flow | $0 | $0 | $0 | $0 | $-2 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | 4,974 | N/A | N/A | N/A |
| Other Financing Activity | 0 | 1,520 | 0 | 0 | 0 |
| Financing Cash Flow | $N/A | $6,495 | $0 | $0 | $0 |
| Exchange Rate Effect | 18 | 14 | -347 | N/A | N/A |
| Beginning Cash Position | 5,876 | 3,921 | 8,904 | 13,759 | 17,176 |
| End Cash Position | 3,332 | 5,876 | 3,921 | 8,904 | 13,759 |
| Net Cash Flow | $-2,562 | $1,941 | $-4,636 | $-4,429 | $-3,418 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,562 | -4,554 | -4,636 | -4,429 | -3,416 |
| Capital Expenditure | N/A | N/A | N/A | N/A | -2 |
| Free Cash Flow | -2,562 | -4,554 | -4,636 | -4,429 | -3,418 |